EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Global Policy and Advocacy Initiatives for Improving Kidney Care

Marina Wainstein iD, Sophanny Tiv iD, Silvia Arruebo, Fergus J Caskey iD, Sandrine Damster, Jo-Ann Donner, Zaghloul Gouda iD, Vivekanand Jha iD, Adeera Levin iD, Masaomi Nangaku iD, Syed Saad iD, Feng Ye iD und 4 weitere

Kidney360 · 2025-03 · 6 (3) · 369-378

DOI: 10.34067/kid.0000000651 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney360, online erschienen am 19.11.2024. Verfasst von Marina Wainstein und 15 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: International Society of Nephrology.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key Points Inclusion and prioritization of CKD and kidney failure within national health strategies are generally lacking. Countries with CKD-specific strategies tend to include and fund a broader spectrum of kidney disease populations and kidney care. Greater global and national prioritization of kidney health are required to reduce global inequities in access to kidney care.

Background

National strategies to address CKD are crucial to support kidney health. Lack of political support in the form of policy decisions and funding leads to fragmentation of kidney care and catastrophic health expenditure. This study used data from the third iteration of the International Society of Nephrology Global Kidney Health Atlas to obtain a global overview of the existence and reach of national strategies for kidney care.

Methods

We leveraged data from an international survey of stakeholders (clinicians, policymakers, and patient advocates) conducted by the International Society of Nephrology between July and September 2022. Data were extracted on existence and scope of national noncommunicable disease (NCD) and/or CKD-specific strategies and policies, as well as recognition of kidney disease as a national health priority through participant perception and existence of CKD advocacy groups.

Results

Overall, stakeholders from 167 countries responded to the survey, representing 97.4% of the global population. National strategies for NCDs were reported by 56% of countries. In 29% of countries, CKD was addressed within an NCD strategy, whereas 25% of countries reported CKD-specific strategies. Countries with CKD-specific strategies were more likely to address all CKD populations (non–dialysis-dependent CKD, chronic dialysis, and kidney transplantation) compared with those with NCD strategies only (51.2% versus 19%). Of the 54% of countries with any CKD strategy, 89% reported public funding of the full spectrum of CKD care compared with 64% of those with no CKD strategy. Kidney failure, CKD, and AKI were reported to be recognized as national health priorities by 63%, 48%, and 19% of countries, respectively.

Conclusions

The inclusion of CKD and kidney failure within national health strategies is frequently lacking. Countries with CKD-specific policies tend to include a broader spectrum of kidney disease populations and to fund kidney care more than those with CKD policies integrated within NCD strategies. Greater global and national prioritization of kidney health are required to reduce global inequities in access to kidney care.

Autor:innen und Institutionen

  • Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.
  • Division of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
  • The International Society of Nephrology, Brussels, Belgium.
  • Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
  • Department of Nephrology, Damanhour Medical National Institute, General Organization of Teaching Hospitals and Institutes, Damanhour, Egypt.
  • George Institute for Global Health, University of New South Wales (UNSW), New Delhi, India.

ORCID-Profile: Marina Wainstein, Sophanny Tiv, Fergus J Caskey, Zaghloul Gouda, Vivekanand Jha, Adeera Levin, Masaomi Nangaku, Syed Saad, Feng Ye, Ikechi G Okpechi, David W Johnson, Valerie A Luyckx

Förderung

  • International Society of Nephrology

Zitieren

APA

Wainstein, M., Tiv, S., Arruebo, S., Caskey, F. J., Damster, S., Donner, J. A., Gouda, Z., Jha, V., Levin, A., Nangaku, M., Saad, S., Ye, F., Okpechi, I. G., Bello, A. K., Johnson, D. W., & Luyckx, V. A. (2025). Global Policy and Advocacy Initiatives for Improving Kidney Care. Kidney360, 6(3), 369-378. https://doi.org/10.34067/kid.0000000651

Vancouver

Wainstein M, Tiv S, Arruebo S, Caskey FJ, Damster S, Donner JA, et al. Global Policy and Advocacy Initiatives for Improving Kidney Care. Kidney360. 2025;6(3):369-378. doi:10.34067/kid.0000000651

BibTeX
@article{Wainstein2025,
  author = {Wainstein, Marina and Tiv, Sophanny and Arruebo, Silvia and Caskey, Fergus J and Damster, Sandrine and Donner, Jo-Ann and Gouda, Zaghloul and Jha, Vivekanand and Levin, Adeera and Nangaku, Masaomi and Saad, Syed and Ye, Feng and Okpechi, Ikechi G and Bello, Aminu K and Johnson, David W and Luyckx, Valerie A},
  title = {Global Policy and Advocacy Initiatives for Improving Kidney Care},
  journal = {Kidney360},
  year = {2025},
  volume = {6},
  number = {3},
  pages = {369--378},
  doi = {10.34067/kid.0000000651}
}
Kostenlos starten →